1 active alerts Show

Community Health Outreach and Education

Cervical Cancer

Lower your risk through vaccines and regular testing.

Lower Your Risk

Human Papillomavirus, or HPV, is the greatest risk factor for cervical cancer. HPV can also cause cancers of the vulva, vagina, anus and oropharynx (part of the throat), and it is the most common sexually transmitted infection. Nearly 80 percent of all women — and men — in the United States carry this cancer-causing virus, but most do not even know they have it.

The American Cancer Society recommends routine HPV vaccination for girls and boys starting at ages 11 or 12.

The Centers for Disease Control recommends two doses of HPV vaccine for all adolescents at age 11 or 12 years. A 3-dose schedule is recommended for those who get the first dose on or after their 15th birthday.

Cervical cancer screening is effective for detecting and preventing cancer of the cervix. HPV and pap testing can alert your provider to abnormalities that can be treated before they actually turn into cancer.

Find a Provider or call us at 800-693-CARE.

Screening for Life and Health Care Connection

Don’t let lack of insurance or copays keep you from getting screened!

Screening for Life and the Health Care Connection Screening for Life provides payment for cancer screening tests recommended by your doctor if you meet age, income and insurance guidelines. This program is a cooperative effort of the Delaware Division of Public Health and the U.S. Centers for Disease Control and Prevention (CDC).

The Health Care Connection simplifies the eligibility screening process to help uninsured Delawareans access primary care and medical specialists, disease prevention services — such as cancer screenings — and helps ensure access to prescription programs, laboratory and radiology services.

Woman with cancer having home session with doctor

Related Content

A medical oncologist administers chemotherapy or immunotherapy to kill cancer cells. The medical oncologists at ChristianaCare employ the latest care.
Global audience in Copenhagen, Denmark, will learn of Gene Editing Institute research targeting the NRF2 gene in cancer cells

Contact Us

Community Health Outreach and Education Program

Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road,
Newark, DE 19713

community-outreach@christianacare.org